NS3 protease of genotype 3 subtype h HCV identified in southeastern France

被引:5
作者
Colson, Philippe [1 ,4 ,5 ]
Gayet, Stephane [2 ]
Gerolami, Rene [3 ]
机构
[1] CHU Timone, Marseille, France
[2] Ctr Hosp Univ St Marguerite, Serv Med Interne & Therapeut, Marseille, France
[3] Ctr Hosp Univ Concept, Serv Hepatogastroenterol, Marseille, France
[4] Univ Aix Marseille 2, Fac Med, CNRS, URMITE,UMR 6236,IRD 198, F-13284 Marseille 07, France
[5] Univ Aix Marseille 2, Fac Pharm, CNRS, URMITE,UMR 6236,IRD 198, F-13284 Marseille 07, France
关键词
HEPATITIS-C; RESISTANCE;
D O I
10.3851/IMP1765
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
HCV displays considerable levels of nucleotide and amino acid diversity. Recently, the relevance of natural polymorphisms in worldwide isolates has been addressed in view of future protease inhibitor (PO-based treatments; genotype- and subtype-specific natural polymorphisms within HCV NS3 protease were identified at amino acid sites associated either with resistance to Pls or with compensatory mutations. Here, we describe a case of chronic infection with HCV of genotype 3 subtype h (HCV-3h), formerly only described from three patients originating from Somalia, and we provide the first NS3 protease sequence for such strains. NS3 protease sequences of HCV-3h recovered in the present study harbour specific amino acid residues not encountered in other reference HCV genotypes and subtypes at nine of the 181 NS3 protease positions; none of these amino acids are known to confer resistance to Pls. Of note, 5' untranslated region sequence-based genotyping classifies them into genotype 1.
引用
收藏
页码:615 / 619
页数:5
相关论文
共 17 条
[1]   A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3 [J].
Abid, K ;
Quadri, R ;
Veuthey, AL ;
Hadengue, A ;
Negro, F .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :1485-1493
[2]   Identification of numerous hepatitis C virus genotypes in Montreal, Canada [J].
Bernier, L ;
Willems, B ;
Delage, G ;
Murphy, DG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (11) :2815-2818
[3]   Chronic hepatitis C virus infection: genotyping and its clinical role [J].
Bowden, D. Scott ;
Berzsenyi, Mark D. .
FUTURE MICROBIOLOGY, 2006, 1 (01) :103-112
[4]   Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice [J].
Chevaliez, Stephane ;
Bouvier-Alias, Magali ;
Brillet, Rozenn ;
Pawlotsky, Jean-Michel .
PLOS ONE, 2009, 4 (12) :1-9
[5]   Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naive chronically infected patient [J].
Colson, Philippe ;
Brouk, Nabil ;
Lembo, Frederique ;
Castellani, Paul ;
Tamalet, Catherine ;
Gerolami, Rene .
HEPATOLOGY, 2008, 47 (02) :766-767
[6]   MUSCLE: multiple sequence alignment with high accuracy and high throughput [J].
Edgar, RC .
NUCLEIC ACIDS RESEARCH, 2004, 32 (05) :1792-1797
[7]   The Los Alamos hepatitis C sequence database [J].
Kuiken, C ;
Yusim, K ;
Boykin, L ;
Richardson, R .
BIOINFORMATICS, 2005, 21 (03) :379-384
[8]  
López-Labrador FX, 2008, ANTIVIR THER, V13, P481
[9]   Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro [J].
Lu, LJ ;
Pilot-Matias, TJ ;
Stewart, KD ;
Randolph, JT ;
Pithawalla, R ;
He, WP ;
Huang, PP ;
Klein, LL ;
Mo, HM ;
Molla, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2260-2266
[10]   Therapy of hepatitis C: From empiricism to eradication [J].
Pawlotsky, JM .
HEPATOLOGY, 2006, 43 (02) :S207-S220